New echocardiographic prognostic factors for mortality in pulmonary arterial hypertension

European Journal of Echocardiography

Volumn 11, Issue 6, 2010, Pages 516-522

  Brierre, Gilles ^a   Blot Souletie, Nathalie ^a   Degano, Bruno ^b   Têtu, Laurent ^a   Bongard, Vanina ^c   Carrié, Didier ^a  

^a CHU RANGUEIL   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Echocardiography; Prognostic factors of mortality; Pulmonary arterial hypertension

Indexed keywords

ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HUMAN; INFERIOR CAVA VEIN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; SCREENING TEST; VEIN DIAMETER; WALKING;

AGED; CONFIDENCE INTERVALS; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FRANCE; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY ARTERY; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC; TIME FACTORS; VENA CAVA, INFERIOR;

EID: 77955467749     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jeq011     Document Type: Article

References (35)

1. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-2537
2. Bossone E, Bodini BD, Mazza A, Allegra L. Pulmonary arterial hypertension: the key role of echocardiography. Chest 2005;127:1836-1843
3. Bossone E, Citro R, Blasi F, Allegra L. Echocardiography in pulmonary arterial hypertension: an essential tool. Chest 2007;131:339-341 (Pubitemid 46280389)
4. Eysmann SB, Palevsky HI, Reichek N, Hackney K, Douglas PS. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 1989;80:353-360
5. Hinderliter AL, Willis PWt, Long W, Clarke WR, Ralph D, Caldwell EJ et al. Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension. Am J Cardiol 1999;84:481-4, A410.
6. Raymond RJ, Hinderliter AL, Willis PW, Ralph D, Caldwell EJ, Williams W et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 2002;39:1214-1219
7. Yeo TC, Dujardin KS, Tei C, Mahoney DW, McGoon MD, Seward JB. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am J Cardiol 1998;81:1157-1161
8. Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, Hemnes AR, Borlaug BA et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006;174:1034-1041
9. McLaughlin VV, Presberg KW, Doyle RL, Abman SH, McCrory DC, Fortin T et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126:78S-92S.
10. McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 2002;106:1477-1482
11. Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000;161:487-492
12. Paciocco G, Martinez FJ, Bossone E, Pielsticker E, Gillespie B, Rubenfire M. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J 2001;17:647-652
13. Wensel R, Opitz CF, Anker SD, Winkler J, Hoffken G, Kleber FX et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002;106:319-324
14. van Wolferen SA, Marcus JT, Boonstra A, Marques KM, Bronzwaer JG, Spreeuwenberg MD et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007;28: 1250-1257
15. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992;327:76-81.
16. Galie N, Ussia G, Passarelli P, Parlangeli R, Branzi A, Magnani B. Role of pharmacologic tests in the treatment of primary pulmonary hypertension. Am J Cardiol 1995;75:55A-62A.
17. Raffy O, Azarian R, Brenot F, Parent F, Sitbon O, Petitpretz P et al. Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension. Circulation 1996;93:484-488
18. Voelkel MA, Wynne KM, Badesch DB, Groves BM, Voelkel NF. Hyperuricemia in severe pulmonary hypertension. Chest 2000;117:19-24.
19. Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998;31:202-208 (Pubitemid 28064743)
20. Nagaya N, Nishikimi T, Uematsu M, Satoh T, Kyotani S, Sakamaki F et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000;102:865-870
21. Nootens M, Kaufmann E, Rector T, Toher C, Judd D, Francis GS et al. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol 1995;26:1581-1585
22. Rubens C, Ewert R, Halank M, Wensel R, Orzechowski HD, Schultheiss HP et al. Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 2001;120:1562-1569
23. Torbicki A, Kurzyna M, Kuca P, Fijalkowska A, Sikora J, Florczyk M et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003;108:844-848
24. Forfia PR, Mathai SC, Fisher MR, Housten-Harris T, Hemnes AR, Champion HC et al. Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med 2008;177:1364-1369
25. Hinderliter AL, Willis PWt, Barst RJ, Rich S, Rubin LJ, Badesch DB et al. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation 1997;95: 1479-1486 (Pubitemid 27142806)
26. Galie N, Hinderliter AL, Torbicki A, Fourme T, Simonneau G, Pulido T et al. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol 2003;41:1380-1386 (Pubitemid 36439000)
27. Badano LP, Ginghina C, Easaw J, Muraru D, Grillo MT, Lancellotti P et al. Right ventricle in pulmonary arterial hypertension: haemodynamics, structural changes, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effects. Eur J Echocardiogr 2010;11:27-37.
28. Tei C, Dujardin KS, Hodge DO, Bailey KR, McGoon MD, Tajik AJ et al. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr 1996;9:838-847
29. Ryan T, Petrovic O, Dillon JC, Feigenbaum H, Conley MJ, Armstrong WF. An echocardiographic index for separation of right ventricular volume and pressure overload. J Am Coll Cardiol 1985;5:918-927
30. Lewis JF, Kuo LC, Nelson JG, Limacher MC, Quinones MA. Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: clinical validation of two new methods using the apical window. Circulation 1984;70:425-431
31. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-54.
32. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115:343-349
33. Kaul S, Tei C, Hopkins JM, Shah PM. Assessment of right ventricular function using two-dimensional echocardiography. Am Heart J 1984;107:526-531
34. Ruan Q, Nagueh SF. Clinical application of tissue Doppler imaging in patients with idiopathic pulmonary hypertension. Chest 2007;131:395-401.
35. Grapsa J, O'Regan DP, Pavlopoulos H, Durighel G, Dawson D, Nihoyannopoulos P. Right ventricular remodelling in pulmonary arterial hypertension with three-dimensional echocardiography: comparison with cardiac magnetic resonance imaging. Eur J Echocardiogr 2010;11:64-73.